Teladoc Health (NYSE:TDOC) Shares Gap Up Following Strong Earnings

Teladoc Health, Inc. (NYSE:TDOC) gapped up before the market opened on Thursday following a stronger than expected earnings report. The stock had previously closed at $6.88, but opened at $7.92. Teladoc Health shares last traded at $8.5020, with a volume of 4,184,026 shares.

The health services provider reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.07. The firm had revenue of $605.10 million for the quarter, compared to analysts’ expectations of $588.14 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%. The company’s revenue was down 3.4% on a year-over-year basis. During the same period in the prior year, the business posted ($0.28) earnings per share.

More Teladoc Health News

Here are the key news stories impacting Teladoc Health this week:

• Positive Sentiment: Teladoc reported third-quarter revenue of $605.1 million, ahead of the approximately $588 million analyst consensus, while its loss of $0.15 per share was narrower than the expected $0.22–$0.23 loss. The company’s year-over-year loss also improved from $0.21–$0.28 per share in the prior-year period. Teladoc Health Reports Third Quarter 2026 Results
• Positive Sentiment: Management raised its full-year 2026 GAAP EPS guidance, giving investors greater confidence that cost controls and operating improvements may continue to reduce losses. Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook
• Positive Sentiment: BetterHelp insurance revenue reached $32 million, providing a potentially important growth channel as Teladoc works to stabilize its broader consumer health business. Teladoc: 3 Key Takeaways for Long-Term Investors
• Neutral Sentiment: Stifel Nicolaus raised its price target from $5.50 to $6.50 but maintained a “hold” rating. Needham also reaffirmed its “hold” rating, suggesting analysts see limited near-term upside after the rally.
• Neutral Sentiment: The stock moved above its 200-day moving average, a technical development that may attract momentum-focused investors, although it does not change the company’s underlying fundamentals. Teladoc Shares Cross Above 200-Day Moving Average
• Negative Sentiment: Revenue declined approximately 3.4% year over year, and Teladoc remains unprofitable, reporting a $26.9 million net loss. Fourth-quarter revenue guidance of roughly $569 million to $615 million is also below or near some analyst expectations, limiting the bullish impact of the earnings beat. Teladoc Provides Fourth-Quarter and Full-Year 2026 Guidance

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Teladoc Health in a research note on Wednesday, August 19th. Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday. Stifel Nicolaus upped their price target on shares of Teladoc Health from $5.50 to $6.50 and gave the company a “hold” rating in a research report on Thursday. Finally, Citigroup reduced their price objective on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research note on Monday, August 3rd. Five equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $7.57.

Insider Transactions at Teladoc Health

In other news, CEO Charles III sold 17,805 shares of the business’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $6.10, for a total transaction of $108,610.50. Following the sale, the chief executive officer owned 465,535 shares in the company, valued at approximately $2,839,763.50. The trade was a 3.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently made changes to their positions in the business. Monaco Asset Management SAM bought a new stake in Teladoc Health in the 2nd quarter valued at $26,864,000. Counterpoint Mutual Funds LLC raised its holdings in shares of Teladoc Health by 1,017.4% during the 3rd quarter. Counterpoint Mutual Funds LLC now owns 1,650,165 shares of the health services provider’s stock worth $9,571,000 after acquiring an additional 1,502,488 shares in the last quarter. Quantinno Capital Management LP raised its holdings in shares of Teladoc Health by 128.0% during the 1st quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock worth $14,287,000 after acquiring an additional 1,471,631 shares in the last quarter. Pale Fire Capital SE boosted its position in shares of Teladoc Health by 74.8% during the 1st quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider’s stock valued at $18,522,000 after acquiring an additional 1,454,288 shares during the last quarter. Finally, Freestone Grove Partners LP bought a new position in shares of Teladoc Health during the 2nd quarter valued at approximately $7,338,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Stock Up 24.6%

The business’s fifty day moving average is $6.15 and its two-hundred day moving average is $6.46. The stock has a market capitalization of $1.56 billion, a PE ratio of -8.59 and a beta of 2.14.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services and technology designed to connect patients with medical professionals remotely. Through its digital platforms, the company supports a range of healthcare needs, including general medical consultations, mental health services, specialty care, and ongoing management of chronic conditions.

Its offerings include telehealth visits with physicians and other licensed providers, behavioral health services through BetterHelp, and chronic care programs that use digital tools and clinical support to help people manage conditions such as diabetes and hypertension.